Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease
- PMID: 17258093
- PMCID: PMC2082057
- DOI: 10.1016/j.jacc.2006.09.038
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease
Abstract
Objectives: The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) population and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality.
Background: Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although diastolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery systolic pressure, and attributable mortality remain unknown.
Methods: Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCD patients. Conventional echocardiographic parameters of diastolic function were performed in a total of 235 SCD patients.
Results: Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hypertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the variability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was associated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p < 0.001), even after adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001).
Conclusions: Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation.
Figures


Comment in
-
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.J Am Coll Cardiol. 2007 Jul 24;50(4):378; author reply 378-9. doi: 10.1016/j.jacc.2007.03.043. Epub 2007 Jul 6. J Am Coll Cardiol. 2007. PMID: 17659206 No abstract available.
Similar articles
-
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.JACC Cardiovasc Imaging. 2016 Mar;9(3):243-52. doi: 10.1016/j.jcmg.2015.05.013. Epub 2016 Feb 17. JACC Cardiovasc Imaging. 2016. PMID: 26897687 Free PMC article. Review.
-
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Circulation. 2011 Sep 27;124(13):1452-60. doi: 10.1161/CIRCULATIONAHA.111.032920. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900080 Free PMC article. Clinical Trial.
-
Ventricular structure and function in children with sickle cell disease using conventional and tissue Doppler echocardiography.Am J Cardiol. 2012 May 1;109(9):1358-64. doi: 10.1016/j.amjcard.2012.01.001. Epub 2012 Feb 15. Am J Cardiol. 2012. PMID: 22341365
-
Right ventricular and pulmonary function in sickle cell disease patients with pulmonary hypertension.Pediatr Cardiol. 2006 Jul-Aug;27(4):440-6. doi: 10.1007/s00246-006-1257-8. Epub 2006 Jul 11. Pediatr Cardiol. 2006. PMID: 16835804
-
Pulmonary hypertension in sickle cell disease: diagnosis and management.Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):425-31. doi: 10.1182/asheducation-2014.1.425. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696889 Review.
Cited by
-
Diffuse myocardial fibrosis as an SCD biomarker.Blood. 2022 Sep 15;140(11):1191-1192. doi: 10.1182/blood.2022017725. Blood. 2022. PMID: 36107457 Free PMC article. No abstract available.
-
Cardiac pathophysiology in sickle cell disease.J Thromb Thrombolysis. 2021 Jul;52(1):248-259. doi: 10.1007/s11239-021-02414-6. Epub 2021 Mar 7. J Thromb Thrombolysis. 2021. PMID: 33677791 Review. No abstract available.
-
Characterizing left ventricular systolic dysfunction in sickle cell disease: three contrasting case reports.Eur Heart J Case Rep. 2024 Aug 14;8(8):ytae383. doi: 10.1093/ehjcr/ytae383. eCollection 2024 Aug. Eur Heart J Case Rep. 2024. PMID: 39144540 Free PMC article.
-
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.Am J Hematol. 2010 Jan;85(1):36-40. doi: 10.1002/ajh.21569. Am J Hematol. 2010. PMID: 20029950 Free PMC article.
-
Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice.Blood Adv. 2019 Dec 10;3(23):4104-4116. doi: 10.1182/bloodadvances.2019000621. Blood Adv. 2019. PMID: 31821458 Free PMC article.
References
-
- Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644. - PubMed
-
- Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol. 2002;33:1037–1043. - PubMed
-
- Manci EA, Culberson DE, Yang YM, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123:359–365. - PubMed
-
- Perronne V, Roberts-Harewood M, Bachir D, et al. Patterns of mortality in sickle cell disease in adults in France and England. Hematol J. 2002;3:56–60. - PubMed
-
- Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886–895. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical